People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | — | Pharmaceuticals | Series A | $9.1M | $280.7M | 2018 |
Keith J Kendall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Keith J Kendall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James S. Scibetta | 1 | 2 |
| Gregory T Brown | 1 | 1 |
| A. Mark T Shobel | 1 | 1 |
| Theresa S Wood | 1 | 1 |
| Douglas T Bratton | 1 | 1 |
| John T Cochran | 1 | 1 |
| Santo S Costa | 1 | 1 |
| Peter S Boyd | 1 | 1 |
| Daniel S Barber | 1 | 1 |
| John T Maxwell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.